Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulçin Gezgin

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|July 24, 2025
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomasMaria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|July 24, 2025
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomasMaria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Pageof 1